Glycan shielding enables TCR-sufficient allogeneic CAR-T therapyZeguang Wu, Wensheng Wei, Jinhong Shi et al.|Cell|2025Cited by 30
Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progressionZhang Li, Yuexiang Wang, Xiaona Jia et al.|Carcinogenesis|2019Cited by 25